dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2018-12-11T17:37:31Z
dc.date.available2018-12-11T17:37:31Z
dc.date.created2018-12-11T17:37:31Z
dc.date.issued2018-01-01
dc.identifierReproductive Toxicology.
dc.identifier1873-1708
dc.identifier0890-6238
dc.identifierhttp://hdl.handle.net/11449/179975
dc.identifier10.1016/j.reprotox.2018.06.012
dc.identifier2-s2.0-85048871577
dc.identifier2-s2.0-85048871577.pdf
dc.identifier3278528112652257
dc.identifier5481756528299469
dc.identifier0000-0003-2938-010X
dc.description.abstractThis study evaluated the protective effects of resveratrol on the prostate development of rats exposed to TCDD. Pregnant rats received TCDD (1 μg/kg) at GD15 and/or RES (20 mg/kg/day) from GD10 to PND21. Newborn and adult males from Control, TCDD, TCDD + RES and RES groups were euthanized and the prostate was excised. On PND1, there was a reduction in the number of prostatic buds, AR-positive mesenchymal cells and proliferation index in epithelial and mesenchymal cells in TCDD group, but restored by RES. AhR immunoreactivity was greater in TCDD group than the other groups. On PND90, there was higher frequency of functional hyperplasia in the distal area of the prostate acini in TCDD group, but restored by RES. AhRR expression was higher in the TCDD while NRF2 was higher in the TCDD + RES compared to the other groups. Resveratrol was able to reduce the adverse effects of TCDD on prostate development and its long-term repercussions.
dc.languageeng
dc.relationReproductive Toxicology
dc.relation0,846
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectProstate development
dc.subjectResveratrol
dc.subjectTCDD
dc.subjectUrogenital sinus
dc.titleProtective effect of resveratrol on urogenital sinus and prostate development in rats exposed in utero to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución